Cincinnati, OH 10/10/17—Meridian Bioscience, a provider of life science products, has named John (Jack) P. Kenney as CEO and a Board member, effective October 9. Most recently, he held the position of senior vice president/general manager, North America, at Siemens Healthcare. Mr. Kenney replaces Chairman and CEO John (Jack) A. Kraeutler, who will become executive chairman. “The Company’s reputation in the marketplace is strong. Meridian has a strong product portfolio, a solid infrastructure, a sound financial position and an exceptional team of employees,” commented Mr. Kenney. “I see opportunities to develop the business based upon both current and new products.”

Mr. Kraeutler’s retirement as CEO was announced in May (see IBO 5/15/17). He had served as CEO since 2008. Publicly held Meridian Bioscience provides research and diagnostic kits, reagents, biologics and components. For the nine-month period ending June 30, company revenues rose 1.3% to $151.1 million. Diagnostics (molecular tests that operate on the illumigene platform and non-molecular tests for multiple platforms) and Life Science (molecular and immunoassay components) sales represented 71% and 29%, of revenues, respectively.